Full View

Key roles of EMT for adaptive resistance to MEK inhibitor in KRAS mutant lung cancer

H Kitai, H Ebi - Small GTPases, 2017 - Taylor & Francis
ABSTRACT KRAS is frequently mutated in a variety of cancers including lung cancer.
Whereas the mitogen-activated protein kinase (MAPK) is a well-known effector pathway of …
被引用次数：33 相关文章
[HTML] nih.gov

[HTML][HTML] Key roles of EMT for adaptive resistance to MEK inhibitor in KRAS mutant lung cancer

H Kitai, H Ebi - Small GTPases, 2017 - ncbi.nlm.nih.gov
ABSTRACT KRAS is frequently mutated in a variety of cancers including lung cancer.
Whereas the mitogen-activated protein kinase (MAPK) is a well-known effector pathway of …

[引用][C] Key roles of EMT for adaptive resistance to MEK inhibitor in KRAS mutant lung cancer

H Kitai, H Ebi - Small GTPases, 2016 - cir.nii.ac.jp
Key roles of EMT for adaptive resistance to MEK inhibitor in <i>KRAS</i> mutant lung cancer |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

Key roles of EMT for adaptive resistance to MEK inhibitor in KRAS mutant lung cancer

H Kitai, H Ebi - Small GTPases, 2017 - pubmed.ncbi.nlm.nih.gov
KRAS is frequently mutated in a variety of cancers including lung cancer. Whereas the
mitogen-activated protein kinase (MAPK) is a well-known effector pathway of KRAS …

Key roles of EMT for adaptive resistance to MEK inhibitor in KRAS mutant lung cancer.

H Kitai, H Ebi - Small Gtpases, 2016 - europepmc.org
ABSTRACT KRAS is frequently mutated in a variety of cancers including lung cancer.
Whereas the mitogen-activated protein kinase (MAPK) is a well-known effector pathway of …

Key roles of EMT for adaptive resistance to MEK inhibitor in KRAS mutant lung cancer.

H Kitai, H Ebi - Small Gtpases, 2016 - europepmc.org
ABSTRACT KRAS is frequently mutated in a variety of cancers including lung cancer.
Whereas the mitogen-activated protein kinase (MAPK) is a well-known effector pathway of …